BNIP3 worked as a good prognostic indicator in pancreatic cancer [38], indicated poor prognosis in cervical cancer [34] and had inconclusive value of clinical outcome prediction in breast cancer [35]. This evidence concerns the gene BNIP3 and familial pancreatic carcinoma.